Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Streptavidin-Cy3: Precision Fluorescent Biotin Detection ...

    2025-12-13

    Streptavidin-Cy3: Precision Fluorescent Biotin Detection Reagent

    Executive Summary: Streptavidin-Cy3 is a conjugate of tetrameric streptavidin and the Cy3 fluorophore, enabling the detection of biotinylated biomolecules with high specificity and sensitivity (APExBIO, product page). The Cy3 dye exhibits a maximum excitation at 554 nm and emission at 568 nm, supporting robust fluorescent labeling in various assays. Each streptavidin molecule binds up to four biotin molecules, facilitating multiplexed detection in immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry (Streptavidin-Cy3: High-Affinity Fluorescent Biotin Detect...). Recent translational studies use Streptavidin-Cy3 to visualize biotinylated targets in cancer metastasis models, providing actionable insights for mechanistic and diagnostic workflows (Illuminating Metastasis: Strategic Insights and Mechanist...). The reagent is stable when stored at 2–8°C, protected from light, and should not be frozen to maintain fluorescence intensity (APExBIO).

    Biological Rationale

    Streptavidin is a 52,800-Da tetrameric protein derived from Streptomyces avidinii. It exhibits near-irreversible binding to biotin with a dissociation constant (Kd) of ~10-15 M, among the strongest known non-covalent interactions in biology (APExBIO). This high affinity allows for specific and robust labeling of biotinylated antibodies, nucleic acids, and proteins in complex samples. Cy3 is a synthetic fluorescent dye with defined excitation (λex = 554 nm) and emission (λem = 568 nm) spectra, producing bright, photostable signals ideal for quantitative and multiplexed imaging (Streptavidin-Cy3: High-Affinity Fluorescent Biotin Detect...). The biotin-streptavidin system is widely used in molecular biology, immunology, and diagnostics due to these properties. In translational oncology, such as studies on nasopharyngeal carcinoma, biotin-based probes and fluorescent conjugates like Streptavidin-Cy3 enable the sensitive visualization of molecular events involved in metastasis (Illuminating Metastasis: Strategic Insights and Mechanist...).

    Mechanism of Action of Streptavidin-Cy3

    Each Streptavidin-Cy3 molecule consists of a streptavidin tetramer covalently conjugated to Cy3 dye molecules. The tetrameric structure provides four high-affinity biotin-binding sites per molecule. Upon incubation with a biotinylated target (e.g., antibody, oligonucleotide, or protein), Streptavidin-Cy3 binds rapidly and stably, forming a labeled complex. The Cy3 moiety emits fluorescence when excited at 554 nm, producing a strong signal at 568 nm. This mechanism enables direct, quantitative detection of biotinylated targets in situ. The fluorescence intensity is proportional to the amount of biotin present, allowing for semi-quantitative analyses in immunohistochemistry (IHC), immunofluorescence (IF), and flow cytometry (Streptavidin-Cy3: Precision Fluorescent Biotin Detection ...). Unbound conjugates are removed by washing, minimizing background.

    Evidence & Benchmarks

    • Streptavidin-Cy3 demonstrates quantitative, low-background detection of biotinylated antibodies in immunofluorescence assays under standard conditions (1:200 dilution, PBS, 2% BSA block, 10 min incubation at room temperature) (APExBIO).
    • In nasopharyngeal carcinoma research, fluorescent streptavidin conjugates enabled precise visualization of biotinylated RNA/DNA probes in situ hybridization, supporting mechanistic studies of NDRG1 pathway activation (Am J Cancer Res 2023;13(8):3781-3798).
    • Multicolor detection is achievable by combining Streptavidin-Cy3 with other fluorophore-conjugated reagents; Cy3’s emission is spectrally distinct from FITC (520 nm) and Cy5 (670 nm) (Streptavidin-Cy3: High-Sensitivity Biotin Detection for T...).
    • Streptavidin-Cy3 retains >90% fluorescence intensity after 6 months of storage at 2–8°C, protected from light (no freeze/thaw cycles) (APExBIO).
    • Compared to enzymatic methods, fluorescent detection with Streptavidin-Cy3 provides higher spatial resolution and multiplexing capability in tissue sections (Streptavidin-Cy3: Precision Fluorescent Biotin Detection ...).

    Applications, Limits & Misconceptions

    Streptavidin-Cy3 (K1079) is validated for use in:

    • Immunohistochemistry (IHC): Detection of biotinylated primary or secondary antibodies in tissue sections (APExBIO).
    • Immunofluorescence (IF) and immunocytochemistry (ICC): Sensitive localization of cell surface or intracellular antigens (Streptavidin-Cy3: High-Affinity Fluorescent Biotin Detect...).
    • Flow cytometry: Quantitative detection of biotinylated markers on or in cells.
    • In situ hybridization (ISH): Fluorescent visualization of biotin-labeled nucleic acid probes in tissue or cell samples (Am J Cancer Res 2023).

    This article extends the guidance provided in Streptavidin-Cy3: Precision Fluorescent Biotin Detection ... by providing fresh benchmarks and updated storage parameters for the K1079 kit.

    Common Pitfalls or Misconceptions

    • Streptavidin-Cy3 is not suitable for enzymatic signal amplification (e.g., HRP/DAB systems); it provides direct fluorescence only.
    • Freezing the reagent can reduce fluorescence intensity and binding performance.
    • Non-specific background may result from incomplete blocking or excess unbound conjugate—optimization of blocking and washing is critical.
    • Cy3 fluorescence can be quenched by prolonged exposure to intense light or by certain mounting media—use anti-fade reagents.
    • Not compatible with biotin-free detection systems or samples pre-saturated with endogenous biotin.

    Workflow Integration & Parameters

    To integrate Streptavidin-Cy3 into workflows:

    • Use at recommended dilutions (e.g., 1:100–1:500) in PBS or Tris-buffered saline, with 1–2% BSA or normal serum for blocking.
    • Incubate with biotinylated targets for 10–30 minutes at room temperature.
    • Wash thoroughly to remove excess unbound conjugate.
    • Protect samples and reagent from direct light to preserve Cy3 fluorescence.
    • Store the Streptavidin-Cy3 conjugate at 2–8°C and avoid freeze/thaw cycles for maximal stability.

    For advanced applications, combine with other spectrally distinct fluorophores for multiplex imaging. Detailed protocols and troubleshooting are available on the APExBIO Streptavidin-Cy3 product page.

    Conclusion & Outlook

    Streptavidin-Cy3 provides a robust, specific, and bright solution for biotin detection in a wide range of biological assays. Its performance is validated in translational oncology, including studies dissecting molecular mechanisms of metastasis in nasopharyngeal carcinoma (Am J Cancer Res 2023). Researchers benefit from its versatility in IHC, IF, ISH, and flow cytometry. The K1079 kit from APExBIO exemplifies stability and reliability for demanding workflows. For an in-depth comparison with other biotin detection strategies, see Streptavidin-Cy3: High-Sensitivity Biotin Detection for T..., which this article updates with new evidence on reagent longevity and spectral compatibility.